Update – Fluoxetine Serious Shortage Protocol extensions
The Department of Health& Social Care (DHSC) has informed us of extensions to the following Serious Shortage Protocols (SSPs). Fluoxetine 40mg capsules The SSP for fluoxetine 40mg capsules is be (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 3, 2020 Category: Drugs & Pharmacology Source Type: news

Effective treatment and prevention of attempted suicide, anxiety and aggressiveness with fluoxetine, despite proven use of androgenic anabolic steroids - Amaral JMX, Padilha MC, Chagas SV, Baker JS, Mullen C, Vieira Neto L, Aquino Neto FR, Cruz MS.
This report includes 30 days of inpatient treatment and a 6-month follow-up. R... (Source: SafetyLit)
Source: SafetyLit - August 21, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Serious shortage protocol (SSP) for fluoxetine - extension
The Department of Health and Social Care (DHSC) issued a Serious Shortage Protocols (SSP) for fluoxetine 40mg capsules. This has been extended to Friday 4 September. Further information on the SSP ca (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 11, 2020 Category: Drugs & Pharmacology Source Type: news

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial - AFFINITY Trial Collaboration.
BACKGROUND: Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethni... (Source: SafetyLit)
Source: SafetyLit - July 27, 2020 Category: International Medicine & Public Health Tags: Falls Source Type: news

Serious shortage protocol (SSP) for fluoxetine - extension
The Department of Health and Social Care (DHSC) issued a Serious Shortage Protocols (SSP) for fluoxetine 40mg capsules. This has been extended to Monday 10 August Further information on the SSP can b (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 16, 2020 Category: Drugs & Pharmacology Source Type: news

Serious shortage protocol (SSP) for fluoxetine (England) - extension
The Department of Health and Social Care (DHSC) issued a Serious Shortage Protocols (SSP) for fluoxetine 10mg tablets. This has been extended to Friday 11 September 2020. Further information on the S (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 2, 2020 Category: Drugs & Pharmacology Source Type: news

Behavioral therapy and fluoxetine treatment in aggressive dogs: a case study - Odore R, Rendini D, Badino P, Gardini G, Cagnotti G, Meucci V, Intorre L, Bellino C, D'Angelo A.
Canine aggression is a major concern, affecting millions of people worldwide, and treatment can be challenging even for skilled veterinarians. Empiric use of fluoxetine is sometimes attempted, although few data regarding long-term effects in aggressive dog... (Source: SafetyLit)
Source: SafetyLit - May 18, 2020 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

Fluoxetine Disappoints in Two New Stroke Trials Fluoxetine Disappoints in Two New Stroke Trials
The antidepressant failed to yield improvements in stroke recovery and was associated with an increase in fracture rates in the EFFECTS and AFFINITY studies.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - May 14, 2020 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news

Aurobindo Pharma gets USFDA nod for generic antidepressant tablets
The company has received the final approval from the US Food and Drug Administration (USFDA) to manufacture and market Fluoxetine tablets in the strengths of 10 mg and 20 mg, Aurobindo Pharma said in a filing to BSE. The tablets are generic version of Eli Lilly's Prozac tablets, it added. The product will be launched in April 2020. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 9, 2020 Category: Pharmaceuticals Source Type: news

Serious shortage protocol (SSP) for Fluoxetine (England)
The Department of Health and Social Care (DHSC) have decided to issue a Serious Shortage Protocols (SSP)... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 12, 2020 Category: Drugs & Pharmacology Source Type: news

Podcast: Selective serotonin reuptake inhibitors for stroke recovery
Stroke is a major cause of death and disability across the world, with many reviews from the Cochrane Stroke Group providing evidence on the effects of treatments and rehabilitation interventions. In November 2019, the Group published their update of their review of selective serotonin reuptake inhibitors and we asked lead author, Gillian Mead from the University of Edinburgh in Scotland, to tell us more.Stroke is a common cause of disability in the community. Although there have been major advances in the care of stroke patients over the last few years, many survivors are still left with physical disability, such as weakn...
Source: Cochrane News and Events - February 26, 2020 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Elizabeth Wurtzel Helped Clear the Air on Stigma Elizabeth Wurtzel Helped Clear the Air on Stigma
"Prozac Nation" author's honesty was good for psychiatry, Dr Robert T. London writes.Medscape Psychiatry (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 14, 2020 Category: Consumer Health News Tags: Psychiatry Commentary Source Type: news

DR MICHAEL MOSLEY: Could magic mushrooms be the new Prozac?
A chemical called psilocybin, originally found in magic mushrooms, is being hailed as a potential lifesaver for people with depression. So is the hype justified, asks DR MICHAEL MOSLEY. (Source: the Mail online | Health)
Source: the Mail online | Health - February 8, 2020 Category: Consumer Health News Source Type: news

Increased circulatory IL-6 during 8-week fluoxetine treatment is a risk factor for suicidal behaviors in youth - Amitai M, Taler M, Ben-Baruch R, Lebow M, Rotkopf R, Apter A, Fennig S, Weizman A, Chen A.
OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) are commonly used to treat anxiety and/or depression in pediatric populations. However, the response rates are low (approximately 50%). Moreover, SSRI use is frequently associated with adverse even... (Source: SafetyLit)
Source: SafetyLit - January 1, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Using antidepressants while pregnant can increase the risk of autism in newborns – study
(Natural News) Pregnant women can add antidepressants to their laundry list of things to avoid during pregnancy. The results of a recent study revealed that babies exposed to the pharmaceutical drug fluoxetine in the womb could develop autistic-like behavior later on. The study, published in the journal Molecular Brain, also identified a potential therapy for the problem,... (Source: NaturalNews.com)
Source: NaturalNews.com - December 3, 2019 Category: Consumer Health News Source Type: news

Amendments to Serious Shortage Protocols for fluoxetine 30mg capsules (England)
The Serious Shortage Protocols (SSP) for fluoxetine 30mg capsules has been varied... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 20, 2019 Category: Drugs & Pharmacology Source Type: news

Amendments to Serious Shortage Protocols for fluoxetine 40mg capsules (England)
The Serious Shortage Protocols (SSP) for fluoxetine 40mg capsules ... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 8, 2019 Category: Drugs & Pharmacology Source Type: news

Amendments to Serious Shortage Protocols for fluoxetine 30mg and 40mg capsules (England)
The Serious Shortage Protocols (SSP) for fluoxetine 30mg capsules and fluoxetine 40mg capsules are being varied to extend the end date, which was previously 31 October 2019. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 30, 2019 Category: Drugs & Pharmacology Source Type: news

Withdrawal of Serious Shortage Protocol for fluoxetine 10mg capsule (England)
The Department of Health and Social Care (DHSC) has issued information about the withdrawal of Serious Shortage Protocol (SSP) for fluoxetine 10mg. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 25, 2019 Category: Drugs & Pharmacology Source Type: news

Effect of Fluoxetine on Repetitive Behaviors in ASD Youth Unclear
WEDNESDAY, Oct. 23, 2019 -- Treatment with fluoxetine results in significantly lower scores for obsessive compulsive behaviors at 16 weeks among children and adolescents with autism spectrum disorder (ASD), according to a study published in the Oct.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 23, 2019 Category: Pharmaceuticals Source Type: news

Antidepressant Prozac Doesn't Ease Obsessive Behaviors of Autism
TUESDAY, Oct. 22, 2019 -- The commonly used antidepressant Prozac doesn't appear to help reduce obsessive-compulsive behavior in children and teens with autism, new research suggests. The study randomly compared use of the drug to a placebo over 16... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 22, 2019 Category: General Medicine Source Type: news

Lexapro vs. Prozac
Title: Lexapro vs. ProzacCategory: MedicationsCreated: 10/21/2019 12:00:00 AMLast Editorial Review: 10/21/2019 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - October 21, 2019 Category: Psychiatry Source Type: news

What are the effects of fluoxetine treatment in overweight or obese adults?
Fluoxetine is a medicine used for the treatment of depression, which reduces appetite as a side effect. Therefore, it is suspected that fluoxetine could be used as a treatment for overweight or obese people. In this group of people administration of fluoxetine means an off-label treatment which means it is not licensed for treating obesity.The authors identified 19 randomised controlled trials (clinical studies where people are randomly put into one of two or more treatment groups) evaluating mainly women receiving different doses of fluoxetine. A total of 1280 overweight or obese participants received fluoxetine and 936 p...
Source: Cochrane News and Events - October 17, 2019 Category: Information Technology Authors: Katie Abbotts Source Type: news

Featured review: What are the effects of fluoxetine treatment in overweight or obese adults?
Fluoxetine is a medicine used for the treatment of depression, which reduces appetite as a side effect. Therefore, it is suspected that fluoxetine could be used as a treatment for overweight or obese people. In this group of people administration of fluoxetine means an off-label treatment which means it is not licensed for treating obesity.The authors identified 19 randomised controlled trials (clinical studies where people are randomly put into one of two or more treatment groups) evaluating mainly women receiving different doses of fluoxetine. A total of 1280 overweight or obese participants received fluoxetine and 936 p...
Source: Cochrane News and Events - October 17, 2019 Category: Information Technology Authors: Katie Abbotts Source Type: news

Serious shortage protocols (SSPs) for Fluoxetine (England)
The Department of Health and Social Care has agreed the October serious shortage protocols for the following items... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 3, 2019 Category: Drugs & Pharmacology Source Type: news

First Serious Shortage Protocols issued
The Government has authorised the first Serious Shortage Protocols (SSP), for the antidepressant fluoxetine, enabling pharmacists in England to supply an alternative strength or pharmaceutical form of (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 3, 2019 Category: Drugs & Pharmacology Source Type: news

NHS doctors warned to limit prescriptions of Prozac because of stock shortages
Doctors in England have been warned not to give patients repeat prescriptions if they have enough of the drug to last until November because the pills are in short supply. (Source: the Mail online | Health)
Source: the Mail online | Health - September 26, 2019 Category: Consumer Health News Source Type: news

Drug Supply issues: Provera100mg tablets and fluoxetine capsules
Information from the Department of Health and Social Care (DHSC) regarding the following supply issues... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 20, 2019 Category: Drugs & Pharmacology Source Type: news

Study shows how serotonin and a popular anti-depressant affect the gut ’s microbiota
In this study, we were interested in finding out why they might do so,” said Hsiao, UCLA assistant professor of integrative biology and physiology, and of microbiology, immunology and molecular genetics in the  UCLA College; and of digestive diseases in the David Geffen School of Medicine at UCLA.Hsiao and her research group reported in the journal Cell in 2015 that in mice, a specific mixture of bacteria, consisting mainly of  Turicibacter sanguinis and Clostridia, produces molecules that signal to gut cells to increase production of serotonin. When Hsiao’s team raised mice without the bact...
Source: UCLA Newsroom: Health Sciences - September 6, 2019 Category: Universities & Medical Training Source Type: news

Psychotherapy Alone First Line of Treatment for Depressed Youth
Adding fluoxetine to cognitive behavioral therapy did not further reduce depressive symptoms (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - August 12, 2019 Category: Psychiatry Tags: Family Medicine, Pediatrics, Pharmacy, Psychiatry, Journal, Source Type: news

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial - Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, Koutsogiannis J, Phelan M, Mullen E, Harrison BJ, Rice S, Parker AG, Dean OM, Weller A, Kerr M, Quinn AL, Catania L, Kazantzis N, McGorry PD, Berk M.
BACKGROUND: Medication is commonly used to treat youth depression, but whether medication should be added to cognitive behavioural therapy (CBT) as first-line treatment is unclear. We aimed to examine whether combined treatment with CBT and fluoxetine was ... (Source: SafetyLit)
Source: SafetyLit - August 4, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

How a popular antidepressant drug could rewire the brain
(American Chemical Society) Prozac ® , the trade name for the drug fluoxetine, was introduced to the US market for the treatment of depression in 1988. Thirty years later, scientists still don't know exactly how the medication exerts its mood-lifting effects. Now, researchers report that, in addition to the drug's known action on serotonin receptors, fluoxetine could rearrange nerve fibers in the hippocampus of mouse brains. They report their results in ACS Chemical Neuroscience. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 10, 2019 Category: International Medicine & Public Health Source Type: news

Medical News Today: What are the differences between Prozac and Zoloft?
Prozac and Zoloft are two types of antidepressant. In this article, we compare the uses, dosages, and side effects of the two drugs. We also look at their interactions with other medicines and discuss whether people can take Prozac and Zoloft together. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 8, 2019 Category: Consumer Health News Tags: Depression Source Type: news

fluoxetine (Prozac, Sarafem, Prozac Weekly)
Title: fluoxetine (Prozac, Sarafem, Prozac Weekly)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 7/3/2019 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - July 3, 2019 Category: Psychiatry Source Type: news

Zoloft (sertraline) vs. Prozac (fluoxetine)
Title: Zoloft (sertraline) vs. Prozac (fluoxetine)Category: MedicationsCreated: 6/26/2019 12:00:00 AMLast Editorial Review: 6/26/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 26, 2019 Category: Drugs & Pharmacology Source Type: news